市場調查報告書
商品編碼
1466729
動物用藥品市場:按交付方式、產品類型、動物類型、最終用戶 - 全球預測 2024-2030Veterinary Medicine Market by Mode of Delivery (Oral, Parenteral), Product (Biologics, Medicated Feed Additives, Pharmaceuticals), Animal Type, End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年動物用藥品市場規模為302.1億美元,預計2024年將達324.7億美元,2030年將達到507.8億美元,複合年成長率為7.69%。
動物用藥品市場包括用於預防、診斷和治療動物疾病的各種醫療產品、服務和解決方案。該市場在確保伴侶動物的健康和福祉以及維持世界各地牲畜的生產力和健康方面發揮著重要作用。市場涵蓋狗、貓、馬等伴同性動物,以及牛、豬、雞等牲畜。動物用藥品在生物安全、營養和動物福利等各個領域都有應用,並涵蓋從常規醫療保健和預防措施到緊急程序的許多最終用途。主要使用者是獸醫醫院和診所、畜牧業者,有時還有寵物飼主。最終用途是由維持動物健康、確保牲畜生產力和防止疾病從動物傳播給人類的需要所驅動的。動物用藥品市場的推動因素包括人們對動物健康和保健意識的提高、伴同性動物擁有率的提高、動物保健支出意願的增加以及對改善牲畜健康的富含蛋白質飲食的需求。 、促進動物健康的政府措施和法規。然而,動物用藥品市場受到獸醫保健服務和產品成本高昂、動物用藥品和產品嚴格的監管核准程序以及低度開發和開拓市場地區獲得獸醫保健機會有限的影響,我們面臨著一些挑戰。同時,透過基因檢測和客製化治療方案開拓個人化醫療,擴大遠距遠端醫療和遠距離診斷和治療的數永續性技術,新疫苗和治療藥物的生物技術創新,以及動物用藥品和畜牧業的發展。的創新和成長提供了許多機會。
主要市場統計 | |
---|---|
基準年[2023] | 302.1億美元 |
預測年份 [2024] | 324.7億美元 |
預測年份 [2030] | 507.8億美元 |
複合年成長率(%) | 7.69% |
產品越來越偏好使用生技藥品來控制動物疾病
獸用生技藥品包括疫苗、單株抗體和其他預防、治療或控制動物疾病的生物製藥。這些產品對於改善動物健康和福利、確保食品安全以及防止疾病從動物傳播給人類至關重要。家畜和伴同性動物的預防保健需求是人們偏好生物製藥的主要驅動力。特別是,由於疫苗在控制感染疾病方面發揮作用,因此對疫苗的需求不斷增加。製藥業包括多種獸藥和治療藥物,包括感染疾病、抗寄生蟲藥和發炎藥物。藥品對於治療動物的某些疾病和病症至關重要。隨著疾病的爆發和新的動物健康問題的出現,對藥品的需求會改變。副作用較少和促進快速復原的治療方法往往是首選。藥用飼料添加劑是一種添加到牲畜飼料中以預防、治療和控制疾病以及提高生長和飼料效率的產品。此類別包括抗生素、益生菌、維生素和礦物質。藥用飼料添加劑在畜牧業中普及使用,以確保健康生長並預防疾病爆發。人們對營養添加劑和益生菌的偏好日益成長,反映出抗生素管理的轉變。由於其在疾病管理中的重要作用,生技藥品在預防醫學中越來越受到青睞,尤其是疫苗。然而,開發和監管核准的複雜性使其成為一個高投資領域。藥物飼料添加劑,特別是非抗生素生長促進劑,因其促進生長和健康的雙重作用而受到青睞,反映了向更永續的畜牧業實踐的轉變。藥物對於標靶治療仍然至關重要,技術創新的重點是開發更安全、更有效的藥物。
最終使用者:擴大動物用藥品在獸醫醫院和診所的使用
獸醫醫院和診所是提供廣泛的動物保健服務的機構,包括醫療、外科和牙科護理。我們經常將內部測試能力與外部實驗室服務結合,以提供全面的護理。參考文獻實驗室是處理更複雜測試的中心設施,通常需要先進的設備和方法。適用於因技術限制或成本問題而無法在內部進行的特殊診斷。照護端 (POC) 或院內檢測是指在病患照護點或附近進行的醫學檢測。該細分市場的主要偏好是立即結果,這對於動物治療的快速決策至關重要。每個細分市場都滿足動物保健市場的獨特需求。就地檢驗即時和便利性而受到青睞,使其成為常規篩檢和即時治療決策的理想選擇。參考文獻實驗室提供各種更複雜和更準確的測試,並受到專業診斷的歡迎。我們的獸醫醫院和診所結合了內部測試和外部實驗室診斷的優勢,提供最全面的護理。
區域洞察
在美國,高寵物擁有率和先進的醫療基礎設施正在推動動物用藥品市場的發展。消費者對優質預防藥物有著強烈的偏好,並且越來越意識到動物健康問題。加拿大對動物照護有很高的標準,並在寵物的健康上花費了大量資金。市場傾向於有機和天然動物用藥品。政府促進動物福利的措施也支持了該產業的成長。由於寵物擁有率上升和動物健康支出增加,南美市場正在見證成長。巴西和阿根廷由於牲畜數量眾多以及對肉類和乳製品的需求不斷成長而處於該區域市場的前沿。由於寵物數量的增加、可支配收入的增加以及動物健康意識的提高,亞太地區正在成為動物用藥品快速成長的地區。在大型畜牧業和不斷上升的寵物擁有率的推動下,中國和印度處於該地區成長的前沿。日本是一個成熟的市場,消費者對寵物健康的意識很高。日本重視創新,已為旨在改善動物福利和管理的動物用藥品和技術解決方案申請了許多專利。歐盟國家對動物健康和動物用藥品有嚴格的規定。該地區擁有強大的獸醫醫療保健系統,消費者對永續和道德產品的需求很高。研究和投資主要針對生物技術和精準醫學,以改善動物健康結果。在中東,隨著人們對動物健康意識的增強,市場正在開拓,特別是在寵物領域。非洲動物用藥品市場面臨獸醫服務機會有限和動物疾病廣泛傳播等挑戰。然而,國際夥伴關係和非政府組織活動旨在透過重點關注疾病根除和獸醫服務能力建設來改善這一狀況。
FPNV定位矩陣
FPNV定位矩陣對於評估動物用藥品市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對動物用藥品市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.動物用藥品市場規模及預測是多少?
2.在動物用藥品市場預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.動物用藥品市場的技術趨勢與法規結構是什麼?
4.動物用藥品市場主要廠商的市場佔有率是多少?
5.進入動物用藥品市場的合適型態和策略性手段是什麼?
[190 Pages Report] The Veterinary Medicine Market size was estimated at USD 30.21 billion in 2023 and expected to reach USD 32.47 billion in 2024, at a CAGR 7.69% to reach USD 50.78 billion by 2030.
The veterinary medicine market encompasses a broad range of medical products, services, and solutions to prevent, diagnose, and treat diseases in animals. This market serves a crucial role in ensuring the health and well-being of pet animals and maintaining the productivity and health of livestock worldwide. This market caters to companion animals such as dogs, cats, and horses and livestock, including cattle, pigs, and poultry. Veterinary medicines find application in various fields, including biosecurity, nutrition, and animal welfare, covering many end uses, from routine healthcare and preventive measures to emergency treatments. The primary users are veterinary hospitals and clinics, livestock farms, and sometimes pet owners directly. The end-use is driven by the necessity for maintaining animal health, ensuring livestock productivity, and preventing disease transmission from animals to humans. The veterinary medicine market is driven by several factors, including rising awareness of animal health and wellness, increasing ownership of companion animals alongside a willingness to spend on animal healthcare, growing demand for protein-rich diets leading to a need for healthier livestock, and government initiatives and regulations promoting animal health. However, the veterinary medicine market faces several challenges, including high costs of veterinary healthcare services and products, stringent regulatory approval processes for veterinary drugs and products, and limited access to veterinary care in underdeveloped and developing regions. On the other hand, the development of personalized medicine through genetic testing and tailored treatment plans, expansion of telemedicine and digital technologies for remote diagnostics and treatment, innovation in biotechnology for novel vaccines and therapeutics, and environmental sustainability in veterinary practice and animal agriculture present numerous opportunities for innovation and growth of the veterinary medicine market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 30.21 billion |
Estimated Year [2024] | USD 32.47 billion |
Forecast Year [2030] | USD 50.78 billion |
CAGR (%) | 7.69% |
Product: Increasing preference for biologics to manage diseases in animals
Biologics for veterinary use include vaccines, monoclonal antibodies, and other biological agents that prevent, treat, or manage diseases in animals. These products are critical for improving animal health and welfare, ensuring food safety, and preventing animal-to-human disease transmission. The need for preventive care in livestock and companion animals primarily drives a preference for biologics. Vaccines are especially in demand for their role in controlling infectious diseases. The pharmaceutical segment encompasses a broad range of drugs and treatments for animals, including anti-infectives, parasiticides, and anti-inflammatory medications. Pharmaceuticals are essential for treating specific diseases and conditions in animals. The demand for pharmaceuticals varies based on the prevalence of diseases and the emergence of new health issues among animals. There is a noted preference for treatments with minimal side effects and those that facilitate rapid recovery. Medicated feed additives are products incorporated into animal feed to prevent, treat, or manage diseases and enhance growth and feed efficiency. This category includes antibiotics, probiotics, vitamins, and minerals. The use of medicated feed additives is prevalent in the livestock sector to ensure healthy growth and to prevent disease outbreaks. There is a growing preference for nutritional additives and probiotics, reflecting the shift towards antibiotic stewardship. Biologics are increasingly favored for preventive care, especially vaccines, due to their crucial role in disease control. However, the complexity of development and regulatory approvals make them a high-investment area. Medicated Feed Additives, particularly non-antibiotic growth promotants, are preferred for their dual role in promoting growth and health, reflecting a shift towards more sustainable animal agriculture practices. Pharmaceuticals remain indispensable for targeted treatments, with innovation focusing on developing safer and more effective drugs.
End-user: Expanding usage of veterinary medicines at veterinary hospitals and clinics
Veterinary hospitals and clinics encompass facilities that provide a broad range of veterinary healthcare services, including medical, surgical, and dental care. They often combine in-house testing capabilities with external laboratory services to offer comprehensive care. Reference laboratories are central facilities that handle more complex tests, often requiring sophisticated equipment or methodologies. They are preferred for specialized diagnostics that cannot be conducted in-house due to technical limitations or cost considerations. Point-of-care (POC) or in-house testing refers to medical examinations conducted at or near the site of patient care. The primary preference for this segment is its immediacy in obtaining results, which is crucial for rapid decision-making in treating animals. Each segment addresses unique needs within the veterinary healthcare market. Point-of-care testing is preferred for its immediacy and convenience, ideal for routine screenings and immediate treatment decisions. Reference laboratories are sought after for specialized diagnostics, offering a broader range of tests with higher complexity and precision. Veterinary hospitals and clinics provide the most comprehensive care, combining the strengths of both in-house testing and external laboratory diagnostics.
Regional Insights
In the United States, the veterinary medicine market is driven by high pet adoption rates and advanced healthcare infrastructure. Consumers strongly prefer premium, preventive medicines and are increasingly aware of animal health issues. Canada has high standards of animal care and significant expenditure on pet health. The market shows a leaning towards organic and natural veterinary products. Government initiatives promoting animal welfare have also encouraged growth in this sector. The South American market is witnessing growth due to the rising adoption of pet animals and increasing expenditure on animal health. Brazil and Argentina are at the forefront of the regional market owing to their large livestock populations and escalating demand for meat and dairy products. APAC is emerging as a rapidly growing region for veterinary medicine due to its expanding pet population, increasing disposable earnings, and raising awareness of animal health. China and India are at the forefront of the region's growth, fueled by their large livestock sectors and increasing pet adoption rates. Japan presents a mature market with high consumer awareness about pet health. The country strongly emphasizes innovation, with numerous patents filed for veterinary pharmaceuticals and technology solutions designed to enhance animal welfare and management. The EU states have stringent regulations governing animal health and veterinary products. This region has a robust veterinary healthcare system and high consumer demand for sustainable and ethical products. Research and investment are strongly directed towards biotechnology and precision medicine to enhance animal health outcomes. In the Middle East, the market is developing with increasing awareness about animal health, especially in the pet sector. Africa's veterinary medicine market faces challenges such as limited access to veterinary services and prevalent animal diseases. However, international collaborations and NGO activities aim to improve the situation by focusing on disease eradication and capacity building for veterinary services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Medicine Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Biogenesis Bago SA, Biopharm company, Biowet Pu??awy sp. z o.o., Brovapharma, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Indian Immunologicals Ltd, Intracin Pharmaceutical Private Limited, JoinHub Pharma, Merck & Co. Inc., Nam Pharma Sdn Bhd, NAPHAVET Co., Ltd., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Sykes Vet International Pty Ltd., TRAVETCO, Vetoquinol S.A., Vetpharma Animal Health S.L., Vetsintez LLC, Virbac SA, Weefsel Pharma, and Zoetis Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Veterinary Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Medicine Market?
3. What are the technology trends and regulatory frameworks in the Veterinary Medicine Market?
4. What is the market share of the leading vendors in the Veterinary Medicine Market?
5. Which modes and strategic moves are suitable for entering the Veterinary Medicine Market?